Introduction
Congenital hypofibrinogenemia is ableeding disordercharacterized by lowfunctional and immunologicalfibrinogen(less than 1.5 g/l). It is usuallycaused by heterozygous mutations in the fibrinogen chains (Aα ,B β ,a nd γ ), and severe cases mayr esult from homozygous or compoundh eterozygousm utations. Approximately5 0m utations responsible for hypofibrinogenemia or afibrinogenemia have beenreported (1) . Most mutations are located in the fibrinogen A α -chaingene ( FGA)and some in the fibrinogen γ -chaingene ( FGG), withonlyafew in the fibrinogen B β -chaingene ( FGB) (2) (3) (4) (5) (6) (7) . Here we report anovel genetic defect in the fibrinogen B β -chainunderlying severe hypofibrinogenemia in aChinese patient. 
Summary
Congenital afibrinogenemia and severe hypofibrinogenemia are severe bleeding disorders characterized by eitherundetectable or very lowlevelsoffibrinogen in patients' plasma and platelets. Amajorityofthe reported casesare caused by mutations in the fibrinogenAα chain. In this study,weidentified agenetic defect in the fibrinogenBβ -chain ( FGB)underlying severe hypofibrinogenemia.Thepropositus frequentlydisplayedbleeding episodes with aprolonged blood-clotting time(thrombin time >180 s,activatedp artial thromboplastin time >3 00 s, prothrombin time >120 s) andhad averylow levelofplasma fibrinogen (1.7-1.8 mg/dl). Hisp arents had ac onsanguineous marriage,and their functional and immunologicalfibrinogen was approximatelyhalf of thenormal level.Theplateletfibrinogen levelofthe proposi-
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Congenital hypofibrinogenemia /afibrinogenemia,fibrinogen / fibrin, gene mutation, plateletaggregation tusc ouldnot be detectedb yw estern blotting, and his platelet aggregation was severely impaired.DNA screening of the whole fibrinogen gene revealedah omozygous GGGG → GGG mutation at nucleotide7969-7972 in his FGB gene.The propositus' parents areboth heterozygous forthis mutation.This mutation contributestoGly419→ Val, and the 419-434 codons areframe shifted, and astop codonisformedatcodon 435.Thepredicted truncatedB β -chain is 27 amino acidss horter thant he normal B β -chain and acentral β -strand in the globular β Cdomain is absent,which mayleadtodestabilization of the entire β -domain.To the best of our knowledge,this is the first reportofsuch amutationwhich is associated with severe hypofibrinogenemia.
Figure1:Platelet fibrinogencontent wasundetectable in the novel FGB gene mutantpatient. Platelet fibrinogenlevelsofthe propositusand familymembers were assayed by Western blot. Thefibrinogen levelofthe propositus' platelets was extremelylow,whereas platelet fibrinogencontentfromhis parents and ahealthy donorwere similar.
Figure2:Platelet aggregationwas impaired in thenovel FGB gene mutantpatient. Platelet aggregationinplateletrich plasmawas induced with10µMadenosine diphosphate(ADP). Theplateletaggregationratio of thepropositus(left) was 20%, his father (center) was 53%, and the healthy donor(right)was 80%.Atleast three independent experimentswereperformed and representative results areshown.
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Materials andmethods
Citrate-anticoagulatedb lood samplesf rom the propositus and hisavailablefamilymemberswere collected forbiochemical and genetic analysis. Informed consent wasobtained for each subject in this studyinaccordance with the Declaration of Helsinki.
Platelet aggregation and coagulation tests
Plateleta ggregation assays were performed using ac omputerized aggregometer( Chrono-logC orporation, Haverton, PA , USA) as we previouslyd escribed (8) . Thea ctivatedp artial thromboplastin time,prothrombin time,thrombin time, and von Willebrand factor (VWF)were measured using routine methods. Plasma functional and immunological fibrinogen levels were determinedu sing the Clauss methoda nd the Immuno-nephelometryassay, respectively.The respective normal valuesfor these assays were 200-400mg/dl and 220-390 mg/dl.
Westernblotanalysis of platelet fibrinogen
It has been reported thatmost plateletfibrinogencomes from the plasma via internalization by the plateletreceptor GPIIIa ( β 3in-tegrin) (9-11). We therefore examinedt he plateletf ibrinogen content in the propositus' familyvia Westernblot. Sepharose2B 
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Xu, Wu,etal. Novelmutationinfibrinogen B β chain gel filtered platelets (5 ×10 7 cells) were lysedi nS DS sample loading buffer,boiled at 100°C for 10 minutes, and subjectto6% SDS-polyacrylamide gelelectrophoresis. Theseparated proteins were transferred to immobilon-Pp olyvinylidene fluoride (PVDF) membrane (Hybond-P,Amersham PharmaciaBiotech, Baie d'Urfe, QC,Canada) and detected with 1:2,000 rabbit antihumanvinculin (internal control, Sigma)and anti-humanfibrinogen( Diagnostica Stago,A snieres, France) using ar outine Westernblot method.
Mutation screening
Polymerase chainreaction (PCR) amplification wasperformed on genomic DNAextractedfrom peripheral blood with aDNA thermal cycler (Perkin-Elmer, Wellesley, MA, USA).T he primersu sedf or sequencing were designedb ased on the sequences of the fibrinogen genesa nd their intergenic regions (Genbank accession numbersM64 982, M64 983, M10 014, and U36 478). PCRproductsw ere detected by electrophoresis on a 1.5% agarose gel and purified with aD NA gel extraction kit (Shanghai Biologic Medical Engineering Co., Shanghai,China). Sequencing of the amplifiedfragmentswas performed using an automatic DNAsequencer (ABI3700; AppleraCo., Foster City, CA,USA).
Results

Case reportand laboratorydata
The propositus is a27-year-old male whohad displayedumbilical cordh emorrhage after birth, followedb yf requent episodes of subcutaneous bleeding,gum bleeding and epistaxis. Laboratory tests showednormal plateletcounts and normal liverfunctions. The patient'splasma clotting indices were prolonged (thrombin time >180 s, activatedpartialthromboplastin time>300 s, and prothrombin time>120 s). The patient'sVWF waswithin the normalr ange, while the fibrinogen levelw as 1.7m g/dl when measured by the Clauss method,and 1.8 mg/dl when assayedby the Immuno-nephelometry. The abnormal coagulation testswere completelyc orrectedb yt he addition of either extrinsic fibrinogen or normal plasma to the patient'sp lasma.P lasma fibrinogen wasassayedinall availablefamilymembers, and the propositus' father, mother, brothera nd the brother'ss on had fibrinogen levels thatw ere approximately 50% of normal. The patient'ssisterhad afibrinogenlevel within the normalrange. The propositus' plateletfibrinogenwas undetectable,but the parents' plateletf ibrinogenc ontents were almostn ormal (Fig. 1) . Furthermore,t he plateleta ggregation ratioo ft he propositus was 20%, his fatherand mother were 53%, and thatofahealthydonor was80% (Fig. 2) . The plateletaggregation exhibited by the propositus maybemediated by residual fibrinogen, plus VWF (12) or other integrin ligandssuch as fibronectin (13) (14) (15) .Otherthan the propositus, the familym embersw ere alla symptomatic and had no obviousbleeding tendenciesorthrombotic complications.
Mutation analysis
Direct sequencing of all of theamplifiedfragmentsfrom A α and γ -chaing enes didn ot detect anym utations, whereas sequence analysis of the B β -chaingene demonstrated anovel homozygous mutation (GGGG→ GGG at nucleotide 7969-7972, numbering according to Genbank M64 983) (Fig. 3) . The mutated region of the B β gene wasPCR-amplifiedfrom the genomic DNAofother TheC-terminal parts of theBβ -and γ -chains form globular β Cand γ C familym embers. The propositus' parents and hisb rother (data not shown) were all heterozygousfor this mutation, whereas the sisterdid not carry this mutation (Fig. 3) .
Discussion
The majority of causative mutations for afibrinogenemia and hypofibrinogenemia aref ound in the FGA gene.C ausativem utations in the FGB gene have beenl essf requently reported. In this study, we identifiedsevere hypofibrinogenemia in apatient bornfrom aconsanguineous marriage. Sequenceanalysis of all threefibrinogengenes revealed anovel homozygous Gdeletion at position 7969-7972 in exon 8ofthe FGB gene.The propositus' parents were heterozygousfor this mutation. Due to this mutation, codon 419 waschangedfrom Gly(ggt) to Va l(gtg), and codons 419-434 were frame-shifted. Furthermore, astop codon wasformed at codon 435. The predicted truncated B β -chainis 27 amino acids shorter than the normal B β -chain. To the best of our knowledge,this is the first causative frame-shift mutation reported in the FGB gene.
Inherited fibrinogen deficiencies mayhavedifferent causes, such as decreased protein synthesis, defective assembly or secretion, increased intracellularorcirculatorydegradation, or acombination of these defects. By transfusing normal fibrinogen products, we found thatextrinsic fibrinogen had anormal half-life in the propositus' circulation, suggesting that the enhancement of circulating fibrinogen degradation maynot be the underlying reasonleading to hypofibrinogenemia in this propositus.
Previous studies indicatedthat synthesis of B β maybearatelimiting factor in the assembly of human fibrinogen (16) .R ecently,t he identification of several mutations hasp rovided insighti nto the B β C-terminald omain. The L353R, G400D (4), G414S(3), W437X (17) and W437G (18) mutations,numbered according to the mature protein, had no effect on the intracellular assembly of the hexamer, butits secretion into the medium wasinhibited. Vu et al. (19) used serial C-terminal truncations of the B β -chaint os tudy the roleo ft his chain in fibrinogen assembly and secretion, and showedthat removalofseven or more residues from the C-terminus of the B β -chainlead to impaired fibrinogen secretion. Together, these studiesd emonstrated that an intact C-terminaldomain of the B β -chainwas necessary for proper fibrinogen secretion. However, it is not clear whether the severe hypofibrinogenemia observedinthe above characterized propositus is solely due to the deficiencyinfibrinogensecretion.
Interestingly, the causativemutation in this patient predicts a stop codon,V435X, whichoccursonlytwo codonsupstreamof the W437X mutation. Examination of the crystals tructureo f fragment Drevealsthat the stop codon at position 435 truncates ar egion of the globular β Cd omain whichi ncludesacentral β -strand as partofa4-stranded section (Fig. 4) .Itisthought that in the β Cand homologous γ Cdomains of the Dfragment,these structural beta strands stabilize the structureand maybeimportant foroverall protein folding (20) . Therefore, it is possible that deletion of this strand maydestabilizethe entire β -domain, perhaps contributing to defective synthesis, assembly,orsecretion of the fibrinogen variant reported here (21, 22) .
In addition to the formation of astop codon at position 435, the Gdeletion and the subsequent frame-shift mutation alters the 17 amino acids between codon 419and codon 434. The contributions of these alterations to fibrinogen synthesis, assembly,and secretion arec urrentlyu nclear.F urther study of the molecular basis of severe hypofibrinogenemia in this patient mayprovide newinsightsinto the protein regions and residues whichare crucial for fibrinogen assembly and secretion, as well as the pathological mechanisms responsiblef or congenital afibrinogenemia.
